Close X
Get more out of WDDTY.com
by joining the site for free
Free 17-point plan to great health
Twice weekly e-news bulletins
Access to our News, Forums and Blogs
Sign up for free and claim your
17-point plan to great health
Free 17-point plan to great health

Twice weekly e-news bulletins

Access to our News, Forums and Blogs
OR

If you want to read our in-depth research articles or
have our amazing magazine delivered to your home
each month, then you have to pay.


Click here if you're interested
Helping you make better health choices

In shops now or delivered to your home from only £3.50 an issue!

Subscribe!

Misclassification of deaths skews cancer trial results
About the author: 
WDDTY Team

Analysis of cancer-screening trials has found major inconsistencies in determining deaths due to all causes and deaths due to specific cancers, thereby casting doubt on the value of the findings of these trials

Analysis of cancer-screening trials has found major inconsistencies in determining deaths due to all causes and deaths due to specific cancers, thereby casting doubt on the value of the findings of these trials.

Researchers from Dartmouth-Hitchcock Medical Center in New Hampshire analysed 12 studies of randomised cancer-screening trials for which data on all-cause and disease-specific mortality were available. Seven were mammography trials, three were faecal occult blood testing and two were chest X-ray screening for lung cancer.

To test the accuracy of the trial findings, the scientists subtracted the disease-specific death rates in the screened populations from those in the controls, and did the same for all-cause mortality rates. They then compared the two different rates of deaths.

Such trials should reveal a greater number of deaths due to specific cancers than from other causes. But, in seven of the 12 trials, there were important inconsistencies. In five of the trials, the differences in the two death rates went in opposite directions, suggesting both positive and negative effects of screening. In four trials, the disease-specific deaths were lower in the screened group than in the controls, but the all-cause mortality was the same or higher in those screened compared with the controls.

In two other trials, while the difference in death rates was more consistent, nevertheless, the difference in all-cause mortality exceeded the disease-specific mortality in the controls.

It is suggested that these differences are mainly the result of biases that led the researchers to misclassify the causes of death.

They recommend that screening trials target those at highest risk because then the ratio of disease-specific to all-cause deaths would be greater than found in the general population. They add that the selection of a high-risk population would also help to avoid the misinterpretation of statistical significance that could make a harmful screening intervention appear to be beneficial or vice versa (J Natl Cancer Inst, 2002; 94: 167-73).


You may also be interested in...

Latest Tweet

About

Since 1989, WDDTY has provided thousands of resources on how to beat asthma, arthritis, depression and many other chronic conditions.

Start by looking in our fully searchable database, active and friendly community forums and the latest health news.

Positive SSL Wildcard

Facebook Twitter

Most Popular Health Website of the Year 2014

© 2010 - 2017 WDDTY Publishing Ltd.
All Rights Reserved